Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics.
about
Psychiatric comorbidities and schizophreniaFluphenazine decanoate (depot) and enanthate for schizophreniaMaintenance treatment with antipsychotic drugs for schizophreniaFluphenazine (oral) versus placebo for schizophreniaFluphenazine (oral) versus placebo for schizophreniaDepot fluphenazine decanoate and enanthate for schizophreniaThe correlates of the syndrome of depression in schizophreniaDifferential diagnosis of depressed mood in patients with schizophrenia: a diagnostic algorithm based on a review.The relationships between depression and remission in first-episode psychosisThe burden of depressive symptoms in the long-term treatment of patients with schizophrenia.Occurrence and treatment of depressive comorbidity/cosyndromality in schizophrenic psychoses: conceptual and treatment issues.New vistas in chronic schizophrenia.Depressive syndromes in schizophrenic patients after discharge from hospital. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich.Differential effect of quetiapine on depressive symptoms in patients with partially responsive schizophrenia.Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.Hopelessness and first-episode psychosis: a longitudinal study.Calgary Depression Scale for Schizophrenia: a study of the validity of a French-language version in a population of schizophrenic patients.Bupropion and thiothixene versus placebo and thiothixene in the treatment of depression in schizophrenia
P2860
Q22242829-215C9A3A-37EF-45B2-A999-5A1984A9216DQ24188205-A1B95CCF-55B8-4135-8C73-9B8463F38B3CQ24197902-6A488B49-D9E2-4A9C-827E-02560CA58798Q24201157-63EE0AA9-E9BA-4748-B73D-73768C0A1756Q24243129-74988618-1535-42DE-B20D-5FFB7FDAF6C8Q24247121-8F941883-E023-4310-B630-496CD992A6F3Q34274561-ADF09504-1FBB-4929-8D77-4CA274D94280Q34744036-72770A65-E716-4AEB-9241-9399E1EF770EQ35129876-E96032A3-8B66-496F-9714-7767A6452395Q35921541-DB1AA92A-5C4E-49FB-8EC2-8A72E71B8B69Q36307088-962CFCAD-1F7F-42ED-BC4A-9630344DFF1BQ39642548-C8478705-3CC9-418B-860D-A550FEF39BCDQ41176006-8AEF1DA4-2EC4-44D0-B819-EA6F05CA88F1Q44518148-95E9DD66-0F10-4BAC-A06D-915743F0F751Q45928081-9737397B-D6A9-48F7-AE1E-784FAEC344DEQ47350118-630688A2-DC96-41B2-AEF6-CC4DBED78D1EQ47768018-C9A13041-3F6C-414E-8A0F-89C279DF67ECQ56961197-3B4E98E9-75B8-4E7E-9A0A-675B4755FEEE
P2860
Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics.
description
1982 nî lūn-bûn
@nan
1982 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
Development and prediction of ...... leptic-treated schizophrenics.
@ast
Development and prediction of ...... leptic-treated schizophrenics.
@en
Development and prediction of ...... leptic-treated schizophrenics.
@nl
type
label
Development and prediction of ...... leptic-treated schizophrenics.
@ast
Development and prediction of ...... leptic-treated schizophrenics.
@en
Development and prediction of ...... leptic-treated schizophrenics.
@nl
prefLabel
Development and prediction of ...... leptic-treated schizophrenics.
@ast
Development and prediction of ...... leptic-treated schizophrenics.
@en
Development and prediction of ...... leptic-treated schizophrenics.
@nl
P2093
P1433
P1476
Development and prediction of ...... leptic-treated schizophrenics.
@en
P2093
Gelenberg AJ
Schooler NR
P304
P356
10.1001/ARCHPSYC.1982.04290020051010
P407
P577
1982-02-01T00:00:00Z